Understanding Lithium Levels in Autism

The Role of Lithium in Autism Spectrum Disorder

Lithium is an intriguing trace mineral that can be taken as a supplement or, at significantly higher doses, used as a treatment for bipolar disorder in children. When taken as a supplement, lithium is both affordable and easily accessible from retailers like iHerb. This blog delves deeper into the subject; however, please seek professional advice before commencing lithium supplementation.

Testing Lithium Levels in Children with Autism

One of my standard assessments for children with Autism Spectrum Disorder (ASD) involves a Whole Blood Elements test. We often find that these children have low or low-normal lithium levels. This finding is noteworthy, as research suggests that low lithium levels may be linked to behavioural issues such as aggression and conduct disorders. Our experience indicates that supplementation with low doses of lithium can enhance behaviour in children with ASD.

The Link Between Environmental Lithium and Behavioural Issues

Studies have established correlations between lower levels of lithium in the environment—such as in drinking water—and increased rates of aggressive behaviour, violence, and behavioural disorders in children and adolescents. Furthermore, lithium has been used therapeutically to help manage aggression, conduct disorder, and bipolar disorder in children. This supports the notion that adequate lithium levels may contribute to emotional and behavioural stability. Lithium is also known to support neurodevelopment, potentially increasing grey matter volume, neurogenesis, and neuronal resilience—factors that are essential for healthy behavioural maturation.

Safety and Efficacy of Lithium Supplementation in Children

Lithium supplementation is generally safe for children. The doses used for treating bipolar disorder in children are usually safe and significantly higher than the amounts typically administered as a supplement. Nevertheless, it is crucial to consult a healthcare professional before beginning lithium supplementation.

Dr Tim Trodd

Family Medicine, Functional Medicine, General Practice

MBBS (London)
DCH (London)
DRCOG (UK)
MRCGP (UK)
FHKAM (Family Medicine)

View Profile View Reports & Publications

Health Articles by Dr Tim Trodd

Interviews

Related Blogs

References

Terao, T., Hirakawa, H., Muronaga, M., Izumi, T., and Kohno, K. (2024) ‘Trace lithium for suicide prevention and dementia prevention: a qualitative review’, Pharmaceuticals, 17(11), pp. 1486. Available at: https://www.mdpi.com/1424-8247/17/11/1486.
Ghamry, M.E., Ibrahim, I.A., Elshazly, S.M., and Fahmy, A. (2025) ‘Pharmacological roles of lithium in treatment of diseases: new insights’, World Veterinary Journal, 15(2), pp. 534-542. Available at: https://wvj.science-line.com/attachments/article/86/WVJ15(2)534-542,2025.pdf.
Kim, H., Park, H.J., Hwang, J., and Kim, S. (2019) ‘Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium’, Nature Reviews Neuroscience, 20, pp. 288-299. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC6494035/.
Chiu, C.T. and Chuang, D.M. (2014) ‘Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders’, Frontiers in Molecular Neuroscience, 7, pp. 1-16. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC4063497/.
Miao, Y. and Zhao, Y. (2018) ‘Molecular mechanisms of lithium action: switching the light on multiple targets for dementia using animal models’, Neuroscience Letters, 674, pp. 119-126. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC6121012/.
Wang, Z. and Wang, F. (2014) ‘Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET study’, Journal of Alzheimer's Disease, 42(2), pp. 623-631. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC4063507/.
Hsu, C.W. and Iwata, N. (2011) ‘Neuroprotective action of lithium in disorders of the central nervous system’, Current Neuropharmacology, 9(2), pp. 276-283. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC3172812/.
Rybakowski, J.K. (2009) ‘In search of the holy grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked?’, Current Medicinal Chemistry, 16(22), pp. 2718-2727. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC1949906/.
Kishi, T. and Iwata, N. (2015) ‘Potential application of lithium in Parkinson's and other neurodegenerative diseases’, Bipolar Disorders, 17(5), pp. 517-524. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC4621308/.
Zhang, J. et al. (2017) ‘Lithium promotes DNA stability and survival of ischemic retinal neurocytes by upregulating DNA ligase IV’, Cell Death & Disease, 8(2), e2598. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC5260892/.
Yildiz, A. et al. (2016) ‘Lithium is clearly underutilized in child psychiatry’, Psychiatric Services, 67(5), pp. 537-538. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC4799589/.
McClellan, J. et al. (2021) ‘Use of lithium in pediatric bipolar disorders and externalizing childhood-related disorders: a systematic review of randomized controlled trials’, Journal of the American Academy of Child & Adolescent Psychiatry, 60(1), pp. 27-36. Available at: https://www.eurekaselect.com/213190/article.
Lee, J. et al. (2023) ‘Putative mechanisms of action and clinical use of lithium in children and adolescents: a critical review’, Frontiers in Psychology, 14, 648247. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC6482478/.
Nassar, A. and Azab, A.N. (2022) ‘Identifying the neuropsychiatric health effects of low-dose lithium interventions: a systematic review’, Psychoneuroendocrinology, 138, 105685. Available at: https://linkinghub.elsevier.com/retrieve/pii/S014976342200464X.
Ueno, Y. et al. (2020) ‘Lithium ameliorates autistic-like behaviors induced by neonatal isolation in rats’, Neuroscience Letters, 718, 134712. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC4071979/.